Skip to content

Author

A. Chehrazi-Raffle

We have 2 of 171 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Vulnerability index impacts distribution of prostate cancer clinical trials in the United States

Background Availability of clinical trials for prostate cancer in the US varies greatly by region. County-level analyses are vital to characterize healthcare access, disease burden, and population-level disparities. Methods Utilizing the ClinicalTrials.gov trial database, we collated all interventional prostate cancer...

Vitor Abreu de Góes, Benjamin D. Mercier, Yu-Jun Li et al. · 0 citations
Open access Sep 2026

13 Molecular and Clinical Characterization of Early-Onset Renal Cell Carcinoma (eoRCC): A Real-World Multi-Omics Analysis

This analysis compares somatic, germline, immune, transcriptomic, and clinical features of eoRCC vs. typical-onset RCC (toRCC) using a multi-omic real-world dataset and reveals upregulation of hypoxia- and VEGFR-signaling pathways in early-onset ccRCC.

H. Ebrahimi, S. Haake, M. Weitz et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.